Adendra Therapeutics
Adendra Therapeutics develop treatments for cancers and autoimmune diseases by applying new insights into regulation of adaptive immune responses by dendritic cells
Adendra Therapeutics has raised €47M across 1 funding round from 1 investor, most recently a Series A round in Dec 2021. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKadendratx.com ↗
Total raised
€47M
€47,014,992
Funding rounds
1
Investors
1
distinct backers
Active since
2021-12
latest 2021-12
Funding by year
EUR raised per yearAdendra Therapeutics — funding by year — interactive chart.
Data table
| Adendra Therapeutics — funding by year | |
|---|---|
| 2021 | €47M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-12 | Series A | €47M | ATP | View deal → |